Investors Menu
Tilray Hosts 2021 Annual Meeting of Shareholders
Chairman and CEO Irwin D. Simon Affirms Global Growth Strategy, Driven by Strong Positioning across the EU, Canada , and the U.S. Tilray’s Leading European Footprint and Market Leadership in Germany Positions the Company to Seize Recreational Cannabis Opportunity NEW YORK , Nov.
November 22, 2021
Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021
NEW YORK , Nov. 16, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. (“ Tilray ”) (Nasdaq: TLRY; TSX: TLRY), invites all stockholders of record to attend the Annual Meeting of Stockholders (“Annual Meeting”) which will be held on November 22, 2021 at 11:00 a.m. EST .
November 16, 2021
Tilray to Participate in Two Jefferies Investor Conferences
NEW YORK , Nov. 11, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. (“Tilray”) (NASDAQ: TLRY; TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, announced that the Company will participate in two Jefferies investor conferences.
November 11, 2021
Tilray Expands Medical Cannabis Footprint in Europe
-- Earns Status as Trusted Supplier of GMP-Certified Medical Cannabis to Luxembourg Ministry of Health -- -- Tilray Branded Medical Cannabis Now Available in 20 Countries Around the World -- NEW YORK --(BUSINESS WIRE)--Oct. 26, 2021-- Tilray, Inc. (“ Tilray ”) (NASDAQ | TSX: TLRY), a global pioneer
October 26, 2021
Tilray Strengthens Leadership Position in Canada
Blair MacNeil , Former Bacardi General Manager, Joins Tilray to Lead the Company’s Canadian Growth Strategy NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Oct. 19, 2021-- Tilray, Inc. (“ Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announces the expansion of its leadership team with the
October 19, 2021
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
Net Revenue and Gross Profit Increased 43% and 46%, Respectively, for Largest Global Cannabis Cultivator 10 th Consecutive Quarter of Positive Adjusted EBITDA $55 Million in Cost-Savings Achieved On a Run-Rate Basis To Date; On-track for at Least $80 Million in Cost-Savings from Aphria and Tilray
October 7, 2021